SEC Form D · filed June 11, 2020
AsclepiX Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Aleksander S. Popel, Phd · Baltimore, MDDirectorJoshua S. Barer · Baltimore, MDDirectorSteven S. Altschuler, Md · Baltimore, MDDirectorSapna S. Srivastava · Baltimore, MDDirectorJordan J. Green · Baltimore, MDDirectorKevin S. Slawin, Md · Baltimore, MDExec · DirectorArt Brown · Vancouver, British Columbia, CanadaDirectorWilliam M. Daniher · Walnut Creek, CADirectorKevin Thieneman · Hilton Head Island, SCDirectorRichard C. Jelinek · Walnut Creek, CADirectorAnkur L. Jain · New York, NYDirectorHironobu C. Tamba · Walnut Creek, CAExec · DirectorChris Kneeland · Calgary, Alberta, CanadaDirectorBrenton K. Ahrens · Dublin, IrelandDirectorMark K. Chin · Dublin, IrelandDirectorPatrick J. Heron · Dublin, IrelandExec · DirectorAnthony Howcroft · Irvine, CADirectorStuart Frost · Irvine, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗